#!/usr/bin/perl

# turn on perl safety features
    use strict;
    use warnings;

# work out the name of the argument we're looking for

my $file_in = $ARGV[0] or die "Must specify file on command line";

#Use module
use XML::Simple;
use Data::Dumper;

# create object
my $xml = new XML::Simple (KeyAttr=>[]);

# read XML file
my $data = $xml->XMLin($file_in);

#declare array node variable
my ($e);

# dereference hash ref
# access reference array
foreach $e (@{$data->{ppsarticleresponse}->{ppsarticleresultset}->{ppsarticle}->{article}})
{
        print $e->{reference}, "\n";
}

exit(0);


##</code><code>##

 <?xml version="1.0" encoding="utf-8"?>
<ppsresponse>
  <ppsarticleresponse xmlns="http://global.factiva.com.ezproxy.insead.edu/pps/2.0">
    <ppsarticleresultset count="133">
      <ppsarticle>
        <article>
          <accessionno>MTPW000020090731e57v004mr</accessionno>
          <reference>distdoc:archive/ArchiveDoc::Article/MTPW000020090731e57v004mr</reference>
          <baselanguage>EN</baselanguage>
          <copyright>(c) 2009 M2 Communications, Ltd. All Rights Reserved.   </copyright>
          <headline>
            <paragraph display="Proportional" truncation="None" lang="EN">Anadys Pharmaceuticals, Inc (NASDAQ:ANDS) is the Highest Percentage Gainers Among NASDAQ Stocks During Morning Trading Hours; Microsoft Corporation (NASDAQ:<hlt>MSFT</hlt>) And Orthofix International NV (NASDAQ:OFIX) Round Out Top Three Percentage Gainers During Morning Trading Hours</paragraph>
          </headline>
          <leadparagraph>
            <paragraph display="Proportional" truncation="None">Dallas, TX - LiquidTycoon.com is pleased to alert investors of stocks on the move.</paragraph>
            <paragraph display="Proportional" truncation="None">Anadys Pharmaceuticals, Inc (NASDAQ:ANDS) is among the gainers on NASDAQ in the early trade hours. The stock is up 60.0% to $2.88 with over 1.63 million shares being traded within few minutes of trade. On July 30, 2009, Anadys Pharmaceuticals, Inc announced the finalization of the protocol for the Company's Phase II trial of ANA598 in combination with pegylated interferon-alpha and ribavirin in hepatitis C patients. Anadys Pharmaceuticals, Inc is a biopharmaceutical company focused to develop medicines in the areas of hepatitis C and oncology. The Company is developing ANA598, a small-molecule, non-nucleoside inhibitor of the NS5B polymerase for the treatment of hepatitis C and ANA773, an oral Toll-like receptor 7 (TLR7) agonist prodrug for the treatment of hepatitis C and cancer.</paragraph>
          </leadparagraph>
          <publicationdate>
            <date>2009-07-31</date>
          </publicationdate>
          <sourcename>M2 Presswire</sourcename>
          <company code="oficks">
            <name>Orthofix International N.V.</name>
            <newsmentions>0</newsmentions>
            <newshits>0</newshits>
          </company>
          <company code="scrptg">
            <name>Anadys Pharmaceuticals Inc</name>
            <newsmentions>0</newsmentions>
            <newshits>0</newshits>
          </company>
          <company code="mcrost">
            <name>Microsoft Corporation</name>
            <newsmentions>0</newsmentions>
            <newshits>0</newshits>
          </company>
          <industry code="i3302">
            <name>Computers/Electronics</name>
          </industry>
          <industry code="i3302021">
            <name>Applications Software</name>
          </industry>
          <industry code="i257">
            <name>Pharmaceuticals</name>
          </industry>
          <industry code="i330202">
            <name>Software</name>
          </industry>
          <industry code="icomp">
            <name>Computing</name>
          </industry>
          <industry code="i3302020">
            <name>Systems Software</name>
          </industry>
          <industry code="i372">
            <name>Medical Equipment/Supplies</name>
          </industry>
          <industry code="i951">
            <name>Health Care</name>
          </industry>
          <industry code="iphmed">
            <name>Medical/Surgical Instruments/Apparatus/Devices</name>
          </industry>
          <region code="usa">
            <name>United States</name>
          </region>
          <region code="namz">
            <name>North American Countries/Regions</name>
          </region>
          <newssubject code="c42" position="0">
            <name>Labor/Personnel Issues</name>
          </newssubject>
          <newssubject code="ghepat" position="0">
            <name>Hepatitis</name>
          </newssubject>
          <newssubject code="mstock" position="0">
            <name>Stock Exchanges</name>
          </newssubject>
          <newssubject code="npress" position="0">
            <name>Press Release</name>
          </newssubject>
          <newssubject code="ccat" position="0">
            <name>Corporate/Industrial News</name>
          </newssubject>
          <newssubject code="gcat" position="0">
            <name>Political/General News</name>
          </newssubject>
          <newssubject code="ghea" position="0">
            <name>Health</name>
          </newssubject>
          <newssubject code="gmed" position="0">
            <name>Medical Conditions</name>
          </newssubject>
          <newssubject code="m11" position="0">
            <name>Equity Markets</name>
          </newssubject>
          <newssubject code="mcat" position="0">
            <name>Commodity/Financial Market News</name>
          </newssubject>
          <newssubject code="ncat" position="0">
            <name>Content Types</name>
          </newssubject>
          <newssubject code="nfact" position="0">
            <name>Factiva Filters</name>
          </newssubject>
          <newssubject code="nfce" position="0">
            <name>FC&amp;E Exclusion Filter</name>
          </newssubject>
          <newssubject code="nfcpin" position="0">
            <name>FC&amp;E Industry News Filter</name>
          </newssubject>
          <sourcecode>MTPW</sourcecode>
          <tailparagraphs>
            <paragraph display="Proportional" truncation="None">Microsoft Corporation (NASDAQ:<hlt>MSFT</hlt>) is gaining momentum in the early morning trading hours. The stock moved up 0.67% to $23.98 on a thinly traded volume of 94k shares within few minutes of trade. On July 30, 2009, Microsoft Corp announced that it is collaborating with comScore Inc to develop a digital media planning solution, named the Reach and Frequency Planner (RF Planner), which will allow brand advertisers to predict reach, frequency and audience composition at the ad placement level. Microsoft Corporation develops, manufactures, licenses and supports a range of software products for computing devices. The Company's software products include operating systems for servers, personal computers and intelligent devices, server applications for distributed computing environments, information worker productivity applications, business solution applications, high-performance computing applications and software development tools and video games.</paragraph>
            <paragraph display="Proportional" truncation="None">Orthofix International NV (NASDAQ:OFIX) climbed over 20.0% to $28.85 on a low traded volume of 94k shares. The 52 week range for the stock is $30.47 and $8.65. On July 30, 2009, Orthofix International N.V. announced that based on its results for the first half of 2009, the Company reaffirmed its fiscal 2009 guidance. Orthofix International N.V. is medical device company offering a line of surgical and non-surgical products for the spine, orthopedics, sports medicine and vascular market sectors. Its products are designed to address the lifelong bone-and-joint health needs of patients of all ages, and to help them achieve a more active and mobile lifestyle.</paragraph>
            <paragraph display="Proportional" truncation="None">Liquid Tycoon alerts its members on stocks that could generate higher than average returns. These include stocks with huge volume, penny stocks that are moving to the upside quickly, penny stocks with buy signals and companies with news. Our alerts are well known for producing incredible results in a short amount of time and our members have made outstanding profits of over 100%.</paragraph>
            <paragraph display="Proportional" truncation="None">ABOUT Liquid Tycoon</paragraph>
            <paragraph display="Proportional" truncation="None">LiquidTycoon.com is a leading stock web site that provides free alerts on stocks that are poised to make big gains. LiquidTycoon.com also tracks small cap penny stocks that could be on the brink of a massive breakout. To feature a company on our web site please contact us at info@ LiquidTycoon.com</paragraph>
            <paragraph display="Proportional" truncation="None">Liquid Tycoon is an independent electronic publication that provides information on selected publicly traded companies. Liquid Tycoon is not a registered investment advisor or broker-dealer. Liquid Tycoon affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.</paragraph>
            <paragraph display="Proportional" truncation="None">M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data prepared by named party/parties. Further information on M2 PressWIRE can be obtained at <elink type="webpage" reference="http://www.presswire.net">http://www.presswire.net</elink> on the world wide web. Inquiries to info@m2.com.</paragraph>
          </tailparagraphs>
          <contact>Liquid Tycoon
 | e-mail: info@LiquidTycoon.com
 | Tel: +1 214 556 6798   </contact>
          <logo source="http://logos.factiva.com.ezproxy.insead.edu" image="mtpwLogo.gif"></logo>
          <wordcount>679</wordcount>
        </article>
        
        <article>
          <accessionno>MTPW000020090731e57v004mr</accessionno>
          <reference>distdoc:archive/ArchiveDoc::Article/MTPW000020090731e57v004mr</reference>
          <baselanguage>EN</baselanguage>
          <copyright>(c) 2009 M2 Communications, Ltd. All Rights Reserved.   </copyright>
          <headline>
            <paragraph display="Proportional" truncation="None" lang="EN">Anadys Pharmaceuticals, Inc (NASDAQ:ANDS) is the Highest Percentage Gainers Among NASDAQ Stocks During Morning Trading Hours; Microsoft Corporation (NASDAQ:<hlt>MSFT</hlt>) And Orthofix International NV (NASDAQ:OFIX) Round Out Top Three Percentage Gainers During Morning Trading Hours</paragraph>
          </headline>
          <leadparagraph>
            <paragraph display="Proportional" truncation="None">Dallas, TX - LiquidTycoon.com is pleased to alert investors of stocks on the move.</paragraph>
            <paragraph display="Proportional" truncation="None">Anadys Pharmaceuticals, Inc (NASDAQ:ANDS) is among the gainers on NASDAQ in the early trade hours. The stock is up 60.0% to $2.88 with over 1.63 million shares being traded within few minutes of trade. On July 30, 2009, Anadys Pharmaceuticals, Inc announced the finalization of the protocol for the Company's Phase II trial of ANA598 in combination with pegylated interferon-alpha and ribavirin in hepatitis C patients. Anadys Pharmaceuticals, Inc is a biopharmaceutical company focused to develop medicines in the areas of hepatitis C and oncology. The Company is developing ANA598, a small-molecule, non-nucleoside inhibitor of the NS5B polymerase for the treatment of hepatitis C and ANA773, an oral Toll-like receptor 7 (TLR7) agonist prodrug for the treatment of hepatitis C and cancer.</paragraph>
          </leadparagraph>
          <publicationdate>
            <date>2009-07-31</date>
          </publicationdate>
          <sourcename>M2 Presswire</sourcename>
          <company code="oficks">
            <name>Orthofix International N.V.</name>
            <newsmentions>0</newsmentions>
            <newshits>0</newshits>
          </company>
          <company code="scrptg">
            <name>Anadys Pharmaceuticals Inc</name>
            <newsmentions>0</newsmentions>
            <newshits>0</newshits>
          </company>
          <company code="mcrost">
            <name>Microsoft Corporation</name>
            <newsmentions>0</newsmentions>
            <newshits>0</newshits>
          </company>
          <industry code="i3302">
            <name>Computers/Electronics</name>
          </industry>
          <industry code="i3302021">
            <name>Applications Software</name>
          </industry>
          <industry code="i257">
            <name>Pharmaceuticals</name>
          </industry>
          <industry code="i330202">
            <name>Software</name>
          </industry>
          <industry code="icomp">
            <name>Computing</name>
          </industry>
          <industry code="i3302020">
            <name>Systems Software</name>
          </industry>
          <industry code="i372">
            <name>Medical Equipment/Supplies</name>
          </industry>
          <industry code="i951">
            <name>Health Care</name>
          </industry>
          <industry code="iphmed">
            <name>Medical/Surgical Instruments/Apparatus/Devices</name>
          </industry>
          <region code="usa">
            <name>United States</name>
          </region>
          <region code="namz">
            <name>North American Countries/Regions</name>
          </region>
          <newssubject code="c42" position="0">
            <name>Labor/Personnel Issues</name>
          </newssubject>
          <newssubject code="ghepat" position="0">
            <name>Hepatitis</name>
          </newssubject>
          <newssubject code="mstock" position="0">
            <name>Stock Exchanges</name>
          </newssubject>
          <newssubject code="npress" position="0">
            <name>Press Release</name>
          </newssubject>
          <newssubject code="ccat" position="0">
            <name>Corporate/Industrial News</name>
          </newssubject>
          <newssubject code="gcat" position="0">
            <name>Political/General News</name>
          </newssubject>
          <newssubject code="ghea" position="0">
            <name>Health</name>
          </newssubject>
          <newssubject code="gmed" position="0">
            <name>Medical Conditions</name>
          </newssubject>
          <newssubject code="m11" position="0">
            <name>Equity Markets</name>
          </newssubject>
          <newssubject code="mcat" position="0">
            <name>Commodity/Financial Market News</name>
          </newssubject>
          <newssubject code="ncat" position="0">
            <name>Content Types</name>
          </newssubject>
          <newssubject code="nfact" position="0">
            <name>Factiva Filters</name>
          </newssubject>
          <newssubject code="nfce" position="0">
            <name>FC&amp;E Exclusion Filter</name>
          </newssubject>
          <newssubject code="nfcpin" position="0">
            <name>FC&amp;E Industry News Filter</name>
          </newssubject>
          <sourcecode>MTPW</sourcecode>
          <tailparagraphs>
            <paragraph display="Proportional" truncation="None">Microsoft Corporation (NASDAQ:<hlt>MSFT</hlt>) is gaining momentum in the early morning trading hours. The stock moved up 0.67% to $23.98 on a thinly traded volume of 94k shares within few minutes of trade. On July 30, 2009, Microsoft Corp announced that it is collaborating with comScore Inc to develop a digital media planning solution, named the Reach and Frequency Planner (RF Planner), which will allow brand advertisers to predict reach, frequency and audience composition at the ad placement level. Microsoft Corporation develops, manufactures, licenses and supports a range of software products for computing devices. The Company's software products include operating systems for servers, personal computers and intelligent devices, server applications for distributed computing environments, information worker productivity applications, business solution applications, high-performance computing applications and software development tools and video games.</paragraph>
            <paragraph display="Proportional" truncation="None">Orthofix International NV (NASDAQ:OFIX) climbed over 20.0% to $28.85 on a low traded volume of 94k shares. The 52 week range for the stock is $30.47 and $8.65. On July 30, 2009, Orthofix International N.V. announced that based on its results for the first half of 2009, the Company reaffirmed its fiscal 2009 guidance. Orthofix International N.V. is medical device company offering a line of surgical and non-surgical products for the spine, orthopedics, sports medicine and vascular market sectors. Its products are designed to address the lifelong bone-and-joint health needs of patients of all ages, and to help them achieve a more active and mobile lifestyle.</paragraph>
            <paragraph display="Proportional" truncation="None">Liquid Tycoon alerts its members on stocks that could generate higher than average returns. These include stocks with huge volume, penny stocks that are moving to the upside quickly, penny stocks with buy signals and companies with news. Our alerts are well known for producing incredible results in a short amount of time and our members have made outstanding profits of over 100%.</paragraph>
            <paragraph display="Proportional" truncation="None">ABOUT Liquid Tycoon</paragraph>
            <paragraph display="Proportional" truncation="None">LiquidTycoon.com is a leading stock web site that provides free alerts on stocks that are poised to make big gains. LiquidTycoon.com also tracks small cap penny stocks that could be on the brink of a massive breakout. To feature a company on our web site please contact us at info@ LiquidTycoon.com</paragraph>
            <paragraph display="Proportional" truncation="None">Liquid Tycoon is an independent electronic publication that provides information on selected publicly traded companies. Liquid Tycoon is not a registered investment advisor or broker-dealer. Liquid Tycoon affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.</paragraph>
            <paragraph display="Proportional" truncation="None">M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data prepared by named party/parties. Further information on M2 PressWIRE can be obtained at <elink type="webpage" reference="http://www.presswire.net">http://www.presswire.net</elink> on the world wide web. Inquiries to info@m2.com.</paragraph>
          </tailparagraphs>
          <contact>Liquid Tycoon
 | e-mail: info@LiquidTycoon.com
 | Tel: +1 214 556 6798   </contact>
          <logo source="http://logos.factiva.com.ezproxy.insead.edu" image="mtpwLogo.gif"></logo>
          <wordcount>679</wordcount>
        </article>

	</ppsarticle>
	</ppsarticleresultset>
	</ppsarticleresponse>
	</ppsresponse>